Scientific Industries, Inc.
SCND · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $2 | $2 | $3 |
| % Growth | -39.7% | -3.2% | -14.4% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $2 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 45.5% | 43.8% | 42.2% | 36.9% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $3 | $3 | $3 |
| Operating Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | -108.4% | -66.3% | -75.3% | -69.5% |
| Other Income/Exp. Net | $6 | $0 | $0 | $0 |
| Pre-Tax Income | $4 | -$2 | -$2 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $4 | -$2 | -$2 | -$2 |
| % Margin | 284.5% | -65.4% | -73.9% | -68.6% |
| EPS | 0.34 | -0.13 | -0.17 | -0.18 |
| % Growth | 361.5% | 23.5% | 5.6% | – |
| EPS Diluted | 0.34 | -0.13 | -0.17 | -0.18 |
| Weighted Avg Shares Out | 12 | 12 | 11 | 11 |
| Weighted Avg Shares Out Dil | 12 | 12 | 11 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $4 | -$1 | -$2 | -$2 |
| % Margin | 295% | -59.7% | -68.3% | -62.9% |